“While now we will have revenues of around RON450 million, we expect to reach RON1 billion in 2030, with a sufficiently high profitability for our business. It’s a main condition for us to develop the human resource, the product portfolio, to become sufficiently internationalized to be able to derive RON500 million per annum from international sales,” stated Ioan Nani, general manager of Antibiotice Iasi.
At present, half of the Iasi plant’s turnover comes from exports.
“We are organized everywhere we export, in Vietnam, the Republic of Moldova, Serbia, we have own offices, in other territories such as the US, Canada, Brazil, Chile, Germany, Switzerland, the Netherlands, India, China, Saudi Arabia we have representation contracts. 50 contracts worldwide. We are territorially present everywhere it’s worth positioning one’s products, we can achieve our mission of having 50% of revenues generated from exports in 2027-2028. Today, we get 50% of turnover from exports, but we do not get as much as we’d want in terms of value”.
(English version by Catalina Apostoiu)